We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.53B
1-Year Est. Return 63.32%
This Fund
S&P 500
This Quarter Est. Return
+18.84%
1 Year Est. Return
+63.32%
3 Year Est. Return
+230.74%
5 Year Est. Return
+346.7%
10 Year Est. Return
+1,599.29%
AUM
$2.76B
AUM Growth
+$318M
Cap. Flow
+$3.28M
Cap. Flow %
0.12%
Top 10 Hldgs %
33.65%
Holding
126
New
10
Increased
35
Reduced
63
Closed
14

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$24.5M
2
NFLX icon
Netflix
NFLX
+$23.9M
3
DGX icon
Quest Diagnostics
DGX
+$23.6M
4
QXO
QXO Inc
QXO
+$20.4M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$19.5M

Sector Composition

Rank Sector Weight
1 Technology 29.99%
2 Financials 14.25%
3 Communication Services 11.45%
4 Industrials 9.49%
5 Healthcare 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSP icon
101
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$601K 0.02%
3,305
-1
-0% -$173
XLF icon
102
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
$593K 0.02%
11,322
-590
-5% -$29.2K
IWF icon
103
iShares Russell 1000 Growth ETF
IWF
$128B
$382K 0.01%
3,596
-1,232
-26% -$118K
VONV icon
104
Vanguard Russell 1000 Value ETF
VONV
$21.2B
$331K 0.01%
3,883
+805
+26% +$65.5K
VO icon
105
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$306K 0.01%
4,368
-400
-8% -$26.3K
XLK icon
106
State Street Technology Select Sector SPDR ETF
XLK
$124B
$298K 0.01%
2,350
-10
-0.4% -$1.11K
VTI icon
107
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
$291K 0.01%
+957
New +$269K
XLU icon
108
State Street Utilities Select Sector SPDR ETF
XLU
$22.5B
$255K 0.01%
6,252
-120
-2% -$4.78K
IWD icon
109
iShares Russell 1000 Value ETF
IWD
$83.7B
$223K 0.01%
1,149
-6
-0.5% -$1.11K
XLY icon
110
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$213K 0.01%
+1,964
New +$201K
ALKT icon
111
Alkami Technology
ALKT
$2.11B
-349,670
Closed -$9.18M
DKNG icon
112
DraftKings
DKNG
$11.9B
-75,630
Closed -$2.51M
DY icon
113
Dycom Industries
DY
$12.3B
-2,827
Closed -$431K
GPN icon
114
Global Payments
GPN
$22.8B
-5,055
Closed -$495K
JNJ icon
115
Johnson & Johnson
JNJ
$625B
-2,400
Closed -$398K
MRVL icon
116
Marvell Technology
MRVL
$196B
-252,409
Closed -$15.5M
NYT icon
117
New York Times
NYT
$10.2B
-60,164
Closed -$2.98M
PEP icon
118
PepsiCo
PEP
$190B
-25,514
Closed -$3.83M
REGN icon
119
Regeneron Pharmaceuticals
REGN
$80.8B
-20,516
Closed -$13M
SRPT icon
120
Sarepta Therapeutics
SRPT
$1.77B
-65,857
Closed -$4.2M
TMO icon
121
Thermo Fisher Scientific
TMO
$220B
-9,952
Closed -$4.95M
TTD icon
122
Trade Desk
TTD
$6.49B
-256,342
Closed -$14M
VRRM icon
123
Verra Mobility
VRRM
$744M
-72,250
Closed -$1.63M
VRTX icon
124
Vertex Pharmaceuticals
VRTX
$126B
-44,672
Closed -$21.7M

Similar funds

Braun Stacey Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Braun Stacey Associates held 126 positions worth $2.76B, up 13% from $2.45B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Braun Stacey Associates's Q2 2025 filing shows 10 new, 35 increased, 63 reduced and 14 closed positions. Its largest new stake was CME Group: 89,918 shares worth $24.8M. The largest sale was Vertex Pharmaceuticals, an estimated $21.7M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Financials and Communication Services.

  • Braun Stacey Associates's largest Q2 2025 buy was CME Group: 89,918 shares worth $24.8M.
  • Braun Stacey Associates added most to Celsius Holdings in Q2 2025, an estimated $13.6M increase.
  • Braun Stacey Associates's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $14.4M.
  • Braun Stacey Associates fully exited Vertex Pharmaceuticals in Q2 2025, selling an estimated $21.7M.
  • Braun Stacey Associates's ten largest holdings make up 34% of its $2.76B portfolio in Q2 2025.
  • Braun Stacey Associates opened 10 new positions and closed 14 in Q2 2025.
  • Braun Stacey Associates's portfolio value rose 13% quarter-over-quarter to $2.76B.

Based on Braun Stacey Associates's 13F filing for Q2 2025, filed 12 Aug 2025.